

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of mitochondrial translation (GO:0070129) | 4.66553812 |
| 2 | nucleobase biosynthetic process (GO:0046112) | 4.52921662 |
| 3 | DNA deamination (GO:0045006) | 4.44374722 |
| 4 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.43336095 |
| 5 | ribosomal small subunit assembly (GO:0000028) | 4.35677384 |
| 6 | purine nucleobase biosynthetic process (GO:0009113) | 4.31555830 |
| 7 | maturation of SSU-rRNA (GO:0030490) | 4.25136322 |
| 8 | DNA strand elongation (GO:0022616) | 4.23968654 |
| 9 | establishment of integrated proviral latency (GO:0075713) | 4.22382444 |
| 10 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.20272284 |
| 11 | formation of translation preinitiation complex (GO:0001731) | 4.19316833 |
| 12 | DNA replication initiation (GO:0006270) | 4.12725163 |
| 13 | ribosomal large subunit biogenesis (GO:0042273) | 4.04222938 |
| 14 | peptidyl-arginine omega-N-methylation (GO:0035247) | 4.02039312 |
| 15 | mitotic metaphase plate congression (GO:0007080) | 3.99254058 |
| 16 | DNA replication checkpoint (GO:0000076) | 3.93632384 |
| 17 | ribosome biogenesis (GO:0042254) | 3.90678480 |
| 18 | chaperone-mediated protein transport (GO:0072321) | 3.89265499 |
| 19 | protein targeting to mitochondrion (GO:0006626) | 3.87173666 |
| 20 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.85931243 |
| 21 | ribosome assembly (GO:0042255) | 3.81781147 |
| 22 | telomere maintenance via recombination (GO:0000722) | 3.81338726 |
| 23 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.80171273 |
| 24 | protein maturation by protein folding (GO:0022417) | 3.78305894 |
| 25 | proteasome assembly (GO:0043248) | 3.72219210 |
| 26 | IMP biosynthetic process (GO:0006188) | 3.71126782 |
| 27 | establishment of viral latency (GO:0019043) | 3.68521588 |
| 28 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.64917605 |
| 29 | DNA unwinding involved in DNA replication (GO:0006268) | 3.63435627 |
| 30 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.63348747 |
| 31 | CENP-A containing nucleosome assembly (GO:0034080) | 3.59975008 |
| 32 | rRNA modification (GO:0000154) | 3.59366279 |
| 33 | establishment of protein localization to mitochondrion (GO:0072655) | 3.56573137 |
| 34 | transcription from mitochondrial promoter (GO:0006390) | 3.55674191 |
| 35 | viral transcription (GO:0019083) | 3.55556544 |
| 36 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.54435539 |
| 37 | regulation of translational termination (GO:0006449) | 3.54043294 |
| 38 | mitotic recombination (GO:0006312) | 3.53735806 |
| 39 | metaphase plate congression (GO:0051310) | 3.52684825 |
| 40 | translational termination (GO:0006415) | 3.52655642 |
| 41 | * rRNA processing (GO:0006364) | 3.51780439 |
| 42 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.50675775 |
| 43 | chromatin remodeling at centromere (GO:0031055) | 3.49243165 |
| 44 | histone arginine methylation (GO:0034969) | 3.48222981 |
| 45 | telomere maintenance via telomere lengthening (GO:0010833) | 3.47954627 |
| 46 | maturation of 5.8S rRNA (GO:0000460) | 3.47206520 |
| 47 | mitotic nuclear envelope disassembly (GO:0007077) | 3.45961580 |
| 48 | regulation of translational fidelity (GO:0006450) | 3.45961560 |
| 49 | ribosomal small subunit biogenesis (GO:0042274) | 3.45935946 |
| 50 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.44961357 |
| 51 | tRNA methylation (GO:0030488) | 3.43249463 |
| 52 | positive regulation of ligase activity (GO:0051351) | 3.41055620 |
| 53 | protein localization to kinetochore (GO:0034501) | 3.41011627 |
| 54 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 3.39915773 |
| 55 | * rRNA metabolic process (GO:0016072) | 3.38814465 |
| 56 | translational initiation (GO:0006413) | 3.37893295 |
| 57 | protein localization to mitochondrion (GO:0070585) | 3.36847172 |
| 58 | peptidyl-histidine modification (GO:0018202) | 3.33669868 |
| 59 | oxidative phosphorylation (GO:0006119) | 3.33637606 |
| 60 | pseudouridine synthesis (GO:0001522) | 3.33350980 |
| 61 | mitochondrial RNA metabolic process (GO:0000959) | 3.30770141 |
| 62 | kinetochore organization (GO:0051383) | 3.29067397 |
| 63 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 3.28425448 |
| 64 | tRNA aminoacylation for protein translation (GO:0006418) | 3.27920374 |
| 65 | spliceosomal snRNP assembly (GO:0000387) | 3.27407676 |
| 66 | proline biosynthetic process (GO:0006561) | 3.26740937 |
| 67 | translational elongation (GO:0006414) | 3.26014371 |
| 68 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.25459102 |
| 69 | IMP metabolic process (GO:0046040) | 3.25035018 |
| 70 | DNA replication-independent nucleosome organization (GO:0034724) | 3.24025945 |
| 71 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.24025945 |
| 72 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.23518556 |
| 73 | tRNA aminoacylation (GO:0043039) | 3.22170326 |
| 74 | amino acid activation (GO:0043038) | 3.22170326 |
| 75 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.20993439 |
| 76 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.19643732 |
| 77 | establishment of chromosome localization (GO:0051303) | 3.19028898 |
| 78 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.18993907 |
| 79 | peptidyl-arginine N-methylation (GO:0035246) | 3.17898340 |
| 80 | peptidyl-arginine methylation (GO:0018216) | 3.17898340 |
| 81 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.16326912 |
| 82 | termination of RNA polymerase III transcription (GO:0006386) | 3.16326912 |
| 83 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.16079295 |
| 84 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.15673611 |
| 85 | membrane disassembly (GO:0030397) | 3.15475923 |
| 86 | nuclear envelope disassembly (GO:0051081) | 3.15475923 |
| 87 | regulation of ligase activity (GO:0051340) | 3.14026403 |
| 88 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.13947044 |
| 89 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.13947044 |
| 90 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.13853076 |
| 91 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.12863922 |
| 92 | GDP-mannose metabolic process (GO:0019673) | 3.12848248 |
| 93 | kinetochore assembly (GO:0051382) | 3.12503096 |
| 94 | transcription-coupled nucleotide-excision repair (GO:0006283) | 3.08953692 |
| 95 | rRNA transcription (GO:0009303) | 3.08895719 |
| 96 | inner mitochondrial membrane organization (GO:0007007) | 3.08592316 |
| 97 | folic acid metabolic process (GO:0046655) | 3.07293824 |
| 98 | regulation of spindle organization (GO:0090224) | 3.05106673 |
| 99 | cotranslational protein targeting to membrane (GO:0006613) | 3.04605666 |
| 100 | protein targeting to ER (GO:0045047) | 3.02708570 |
| 101 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.02265525 |
| 102 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.01885855 |
| 103 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.98117744 |
| 104 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.98117744 |
| 105 | protein localization to chromosome, centromeric region (GO:0071459) | 2.97179392 |
| 106 | rRNA methylation (GO:0031167) | 2.96360255 |
| 107 | positive regulation of cell cycle arrest (GO:0071158) | 2.96136881 |
| 108 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 2.95441347 |
| 109 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.95166529 |
| 110 | negative regulation of ligase activity (GO:0051352) | 2.95166529 |
| 111 | cullin deneddylation (GO:0010388) | 2.94937362 |
| 112 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.93918766 |
| 113 | cell cycle G1/S phase transition (GO:0044843) | 2.93825073 |
| 114 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.93825073 |
| 115 | viral mRNA export from host cell nucleus (GO:0046784) | 2.93334094 |
| 116 | negative regulation of mRNA processing (GO:0050686) | 2.92778532 |
| 117 | translation (GO:0006412) | 2.92573466 |
| 118 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.91441382 |
| 119 | cellular component biogenesis (GO:0044085) | 2.90576787 |
| 120 | regulation of translation in response to stress (GO:0043555) | 2.90031732 |
| 121 | histone exchange (GO:0043486) | 2.89961758 |
| 122 | purine nucleotide salvage (GO:0032261) | 2.89201094 |
| 123 | nuclear pore organization (GO:0006999) | 2.88563388 |
| 124 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.87850246 |
| 125 | regulation of cellular amine metabolic process (GO:0033238) | 2.87845872 |
| 126 | protein localization to endoplasmic reticulum (GO:0070972) | 2.87004737 |
| 127 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.86944781 |
| 128 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.85982321 |
| 129 | metallo-sulfur cluster assembly (GO:0031163) | 2.85853820 |
| 130 | iron-sulfur cluster assembly (GO:0016226) | 2.85853820 |
| 131 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.85337745 |
| 132 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.84006646 |
| 133 | termination of RNA polymerase I transcription (GO:0006363) | 2.83908847 |
| 134 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.81133348 |
| 135 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.81133348 |
| 136 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.81133348 |
| 137 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.80598202 |
| 138 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.80598202 |
| 139 | regulation of double-strand break repair via homologous recombination (GO:0010569) | 2.79728892 |
| 140 | transcription elongation from RNA polymerase I promoter (GO:0006362) | 2.78467573 |
| 141 | attachment of spindle microtubules to kinetochore (GO:0008608) | 2.78194327 |
| 142 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.78182393 |
| 143 | * ncRNA processing (GO:0034470) | 2.77266683 |
| 144 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.76732162 |
| 145 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.76732162 |
| 146 | 7-methylguanosine mRNA capping (GO:0006370) | 2.76687445 |
| 147 | cellular protein complex disassembly (GO:0043624) | 2.76361348 |
| 148 | telomere organization (GO:0032200) | 2.76138502 |
| 149 | transcription from RNA polymerase I promoter (GO:0006360) | 2.75952763 |
| 150 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.75357593 |
| 151 | telomere maintenance (GO:0000723) | 2.74678812 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.59662471 |
| 2 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.22421495 |
| 3 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.62642368 |
| 4 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.50307727 |
| 5 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.31086112 |
| 6 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.20449488 |
| 7 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.18741436 |
| 8 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.13666684 |
| 9 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.10084143 |
| 10 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.92087341 |
| 11 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.87330564 |
| 12 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.87314412 |
| 13 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.87009058 |
| 14 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.80957429 |
| 15 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.68015422 |
| 16 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.67451930 |
| 17 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.44974446 |
| 18 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.44620537 |
| 19 | * VDR_23849224_ChIP-Seq_CD4+_Human | 2.37904127 |
| 20 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.30622257 |
| 21 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.26547280 |
| 22 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.24658165 |
| 23 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.13313671 |
| 24 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.09442776 |
| 25 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.05446880 |
| 26 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.04978662 |
| 27 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.02556670 |
| 28 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.93774044 |
| 29 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.92801012 |
| 30 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.91886589 |
| 31 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.89591085 |
| 32 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.84833644 |
| 33 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.79798600 |
| 34 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.78911362 |
| 35 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.77005023 |
| 36 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.76532914 |
| 37 | * TTF2_22483619_ChIP-Seq_HELA_Human | 1.76214974 |
| 38 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.75920932 |
| 39 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.75418354 |
| 40 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.74301278 |
| 41 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.71769261 |
| 42 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.70579655 |
| 43 | * NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.66482042 |
| 44 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.66271935 |
| 45 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.65998183 |
| 46 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.65415188 |
| 47 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.63264372 |
| 48 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.61513257 |
| 49 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.60394372 |
| 50 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.58654499 |
| 51 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.56251963 |
| 52 | * YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.54067546 |
| 53 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.52366167 |
| 54 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.51184395 |
| 55 | MYC_22102868_ChIP-Seq_BL_Human | 1.48622339 |
| 56 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47740753 |
| 57 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.45096542 |
| 58 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.44506266 |
| 59 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.43540292 |
| 60 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.42004791 |
| 61 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.41123855 |
| 62 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.41034029 |
| 63 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.40429416 |
| 64 | * ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.38624242 |
| 65 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.37278985 |
| 66 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.33443114 |
| 67 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.28669392 |
| 68 | * SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.27688273 |
| 69 | * PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.25497440 |
| 70 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.19002405 |
| 71 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.18405017 |
| 72 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.18383792 |
| 73 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.16928783 |
| 74 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.14750883 |
| 75 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.14083835 |
| 76 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.13137523 |
| 77 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.11611260 |
| 78 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.11000288 |
| 79 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.07990161 |
| 80 | * HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.07870905 |
| 81 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.07652694 |
| 82 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.07194477 |
| 83 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.04033455 |
| 84 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.03364038 |
| 85 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.02113825 |
| 86 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.01923149 |
| 87 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.01390152 |
| 88 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.99869724 |
| 89 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.99702268 |
| 90 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.99102942 |
| 91 | * DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.98191656 |
| 92 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.97555391 |
| 93 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.96424253 |
| 94 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.96183400 |
| 95 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.95770475 |
| 96 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.95644153 |
| 97 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.94146885 |
| 98 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.94085667 |
| 99 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.91971727 |
| 100 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.90942202 |
| 101 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.90735001 |
| 102 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.89381317 |
| 103 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.89243522 |
| 104 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.89095854 |
| 105 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.88120098 |
| 106 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.87362552 |
| 107 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.85020915 |
| 108 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.82832925 |
| 109 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.82301771 |
| 110 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.81701579 |
| 111 | * CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.81679961 |
| 112 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.81434930 |
| 113 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.80144924 |
| 114 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.79621599 |
| 115 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.79458297 |
| 116 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.79361492 |
| 117 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78653026 |
| 118 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.78454814 |
| 119 | MYB_26560356_Chip-Seq_TH1_Human | 0.76973979 |
| 120 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.76938764 |
| 121 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.75977348 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 5.38737203 |
| 2 | MP0010094_abnormal_chromosome_stability | 4.15796257 |
| 3 | MP0004957_abnormal_blastocyst_morpholog | 4.07543955 |
| 4 | MP0003111_abnormal_nucleus_morphology | 4.05464319 |
| 5 | MP0008057_abnormal_DNA_replication | 3.75110066 |
| 6 | MP0003077_abnormal_cell_cycle | 3.70335935 |
| 7 | MP0008058_abnormal_DNA_repair | 3.36060501 |
| 8 | MP0006035_abnormal_mitochondrial_morpho | 3.06646863 |
| 9 | MP0005451_abnormal_body_composition | 3.01801138 |
| 10 | MP0002396_abnormal_hematopoietic_system | 2.94196125 |
| 11 | MP0008007_abnormal_cellular_replicative | 2.92834470 |
| 12 | MP0006036_abnormal_mitochondrial_physio | 2.85496740 |
| 13 | MP0008932_abnormal_embryonic_tissue | 2.36116104 |
| 14 | MP0004233_abnormal_muscle_weight | 1.96186621 |
| 15 | MP0001730_embryonic_growth_arrest | 1.94410392 |
| 16 | MP0000490_abnormal_crypts_of | 1.93509661 |
| 17 | MP0003763_abnormal_thymus_physiology | 1.90282568 |
| 18 | MP0000350_abnormal_cell_proliferation | 1.86217900 |
| 19 | MP0003718_maternal_effect | 1.85862162 |
| 20 | MP0003786_premature_aging | 1.85081083 |
| 21 | MP0009333_abnormal_splenocyte_physiolog | 1.84140614 |
| 22 | MP0003123_paternal_imprinting | 1.76427535 |
| 23 | MP0003806_abnormal_nucleotide_metabolis | 1.74877735 |
| 24 | MP0002132_abnormal_respiratory_system | 1.74630988 |
| 25 | MP0005501_abnormal_skin_physiology | 1.61693490 |
| 26 | MP0010307_abnormal_tumor_latency | 1.60701212 |
| 27 | MP0001835_abnormal_antigen_presentation | 1.58828270 |
| 28 | MP0010352_gastrointestinal_tract_polyps | 1.58665680 |
| 29 | MP0002796_impaired_skin_barrier | 1.57449053 |
| 30 | MP0002398_abnormal_bone_marrow | 1.54567947 |
| 31 | MP0004808_abnormal_hematopoietic_stem | 1.51842296 |
| 32 | MP0008877_abnormal_DNA_methylation | 1.50484727 |
| 33 | MP0005670_abnormal_white_adipose | 1.49783164 |
| 34 | MP0002019_abnormal_tumor_incidence | 1.47961918 |
| 35 | MP0005671_abnormal_response_to | 1.46817705 |
| 36 | MP0000313_abnormal_cell_death | 1.43996493 |
| 37 | MP0001873_stomach_inflammation | 1.43497355 |
| 38 | MP0005380_embryogenesis_phenotype | 1.42960780 |
| 39 | MP0001672_abnormal_embryogenesis/_devel | 1.42960780 |
| 40 | MP0000689_abnormal_spleen_morphology | 1.42199203 |
| 41 | MP0005397_hematopoietic_system_phenotyp | 1.41633982 |
| 42 | MP0001545_abnormal_hematopoietic_system | 1.41633982 |
| 43 | MP0002722_abnormal_immune_system | 1.41026074 |
| 44 | MP0001697_abnormal_embryo_size | 1.37955691 |
| 45 | MP0001661_extended_life_span | 1.37440618 |
| 46 | MP0001727_abnormal_embryo_implantation | 1.36659350 |
| 47 | MP0002080_prenatal_lethality | 1.35144485 |
| 48 | MP0003186_abnormal_redox_activity | 1.32833314 |
| 49 | MP0003984_embryonic_growth_retardation | 1.32339858 |
| 50 | MP0000703_abnormal_thymus_morphology | 1.31969529 |
| 51 | MP0004185_abnormal_adipocyte_glucose | 1.29302871 |
| 52 | MP0002088_abnormal_embryonic_growth/wei | 1.28462694 |
| 53 | MP0001800_abnormal_humoral_immune | 1.28288639 |
| 54 | MP0005075_abnormal_melanosome_morpholog | 1.25069864 |
| 55 | MP0001881_abnormal_mammary_gland | 1.24915109 |
| 56 | MP0002429_abnormal_blood_cell | 1.24642994 |
| 57 | MP0008995_early_reproductive_senescence | 1.23983082 |
| 58 | MP0000716_abnormal_immune_system | 1.19808060 |
| 59 | MP0001853_heart_inflammation | 1.18445530 |
| 60 | MP0002452_abnormal_antigen_presenting | 1.16841081 |
| 61 | MP0009785_altered_susceptibility_to | 1.16744922 |
| 62 | MP0002420_abnormal_adaptive_immunity | 1.16489988 |
| 63 | MP0001819_abnormal_immune_cell | 1.14819227 |
| 64 | MP0006292_abnormal_olfactory_placode | 1.13126061 |
| 65 | MP0003436_decreased_susceptibility_to | 1.12362495 |
| 66 | MP0002723_abnormal_immune_serum | 1.10809297 |
| 67 | MP0002086_abnormal_extraembryonic_tissu | 1.10132371 |
| 68 | MP0002163_abnormal_gland_morphology | 1.09866911 |
| 69 | MP0000858_altered_metastatic_potential | 1.09788070 |
| 70 | MP0001293_anophthalmia | 1.09067027 |
| 71 | MP0000465_gastrointestinal_hemorrhage | 1.08508880 |
| 72 | MP0002085_abnormal_embryonic_tissue | 1.07372198 |
| 73 | MP0003941_abnormal_skin_development | 1.06631102 |
| 74 | MP0010234_abnormal_vibrissa_follicle | 1.06393930 |
| 75 | MP0000685_abnormal_immune_system | 1.04229494 |
| 76 | MP0005000_abnormal_immune_tolerance | 1.03549939 |
| 77 | MP0003567_abnormal_fetal_cardiomyocyte | 1.02976563 |
| 78 | MP0004197_abnormal_fetal_growth/weight/ | 1.00151080 |
| 79 | MP0000678_abnormal_parathyroid_gland | 1.00000123 |
| 80 | MP0005025_abnormal_response_to | 0.99744780 |
| 81 | MP0002405_respiratory_system_inflammati | 0.98515900 |
| 82 | MP0002970_abnormal_white_adipose | 0.97957976 |
| 83 | MP0002210_abnormal_sex_determination | 0.94520664 |
| 84 | MP0005058_abnormal_lysosome_morphology | 0.92396967 |
| 85 | MP0005330_cardiomyopathy | 0.89638763 |
| 86 | MP0002877_abnormal_melanocyte_morpholog | 0.87889338 |
| 87 | MP0001119_abnormal_female_reproductive | 0.87679024 |
| 88 | MP0002084_abnormal_developmental_patter | 0.87394445 |
| 89 | MP0002095_abnormal_skin_pigmentation | 0.84289175 |
| 90 | MP0001145_abnormal_male_reproductive | 0.83407309 |
| 91 | MP0010155_abnormal_intestine_physiology | 0.83186523 |
| 92 | MP0009278_abnormal_bone_marrow | 0.81911573 |
| 93 | MP0002148_abnormal_hypersensitivity_rea | 0.81496378 |
| 94 | MP0008260_abnormal_autophagy | 0.79231829 |
| 95 | MP0002006_tumorigenesis | 0.78533650 |
| 96 | MP0005266_abnormal_metabolism | 0.77551997 |
| 97 | MP0009379_abnormal_foot_pigmentation | 0.77526605 |
| 98 | MP0000015_abnormal_ear_pigmentation | 0.76907448 |
| 99 | MP0002419_abnormal_innate_immunity | 0.76554465 |
| 100 | MP0002160_abnormal_reproductive_system | 0.76370815 |
| 101 | MP0005645_abnormal_hypothalamus_physiol | 0.76344232 |
| 102 | MP0002269_muscular_atrophy | 0.75125908 |
| 103 | MP0000358_abnormal_cell_content/ | 0.73941189 |
| 104 | MP0000653_abnormal_sex_gland | 0.73657674 |
| 105 | MP0002822_catalepsy | 0.71480066 |
| 106 | MP0001790_abnormal_immune_system | 0.71307978 |
| 107 | MP0005387_immune_system_phenotype | 0.71307978 |
| 108 | MP0001764_abnormal_homeostasis | 0.71294919 |
| 109 | MP0005666_abnormal_adipose_tissue | 0.70997678 |
| 110 | MP0009840_abnormal_foam_cell | 0.70959444 |
| 111 | MP0000627_abnormal_mammary_gland | 0.70570356 |
| 112 | MP0003221_abnormal_cardiomyocyte_apopto | 0.69995790 |
| 113 | MP0005174_abnormal_tail_pigmentation | 0.69446381 |
| 114 | MP0009697_abnormal_copulation | 0.69022384 |
| 115 | MP0005464_abnormal_platelet_physiology | 0.69017213 |
| 116 | MP0005389_reproductive_system_phenotype | 0.68994371 |
| 117 | MP0001929_abnormal_gametogenesis | 0.68137933 |
| 118 | MP0003448_altered_tumor_morphology | 0.67599266 |
| 119 | MP0000747_muscle_weakness | 0.67331509 |
| 120 | MP0005384_cellular_phenotype | 0.67162325 |
| 121 | MP0001845_abnormal_inflammatory_respons | 0.66548657 |
| 122 | MP0006054_spinal_hemorrhage | 0.66357775 |
| 123 | MP0005408_hypopigmentation | 0.65875851 |
| 124 | MP0000372_irregular_coat_pigmentation | 0.63951693 |
| 125 | MP0005621_abnormal_cell_physiology | 0.63731646 |
| 126 | MP0003315_abnormal_perineum_morphology | 0.63653262 |
| 127 | MP0002166_altered_tumor_susceptibility | 0.63334533 |
| 128 | MP0000477_abnormal_intestine_morphology | 0.62546078 |
| 129 | MP0002254_reproductive_system_inflammat | 0.62526678 |
| 130 | MP0003191_abnormal_cellular_cholesterol | 0.62415787 |
| 131 | MP0003121_genomic_imprinting | 0.62174000 |
| 132 | MP0001216_abnormal_epidermal_layer | 0.61831374 |
| 133 | MP0009672_abnormal_birth_weight | 0.61602367 |
| 134 | MP0000467_abnormal_esophagus_morphology | 0.60606164 |
| 135 | MP0000749_muscle_degeneration | 0.60424805 |
| 136 | MP0008873_increased_physiological_sensi | 0.58533825 |
| 137 | MP0000613_abnormal_salivary_gland | 0.56504426 |
| 138 | MP0005332_abnormal_amino_acid | 0.55778170 |
| 139 | MP0002060_abnormal_skin_morphology | 0.54164394 |
| 140 | MP0001529_abnormal_vocalization | 0.53332841 |
| 141 | MP0005310_abnormal_salivary_gland | 0.53077577 |
| 142 | MP0010771_integument_phenotype | 0.52565423 |
| 143 | MP0005452_abnormal_adipose_tissue | 0.51518681 |
| 144 | MP0005319_abnormal_enzyme/_coenzyme | 0.50081691 |
| 145 | MP0000003_abnormal_adipose_tissue | 0.50050806 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Birth length less than 3rd percentile (HP:0003561) | 5.00245500 |
| 2 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.55162614 |
| 3 | Reticulocytopenia (HP:0001896) | 4.48004792 |
| 4 | Acute necrotizing encephalopathy (HP:0006965) | 4.41721876 |
| 5 | Abnormality of glycolysis (HP:0004366) | 4.21011637 |
| 6 | Acute encephalopathy (HP:0006846) | 4.10564732 |
| 7 | Increased serum pyruvate (HP:0003542) | 3.98786850 |
| 8 | Hepatocellular necrosis (HP:0001404) | 3.96766497 |
| 9 | Mitochondrial inheritance (HP:0001427) | 3.94761359 |
| 10 | Abnormal number of erythroid precursors (HP:0012131) | 3.86500590 |
| 11 | Breast hypoplasia (HP:0003187) | 3.84203971 |
| 12 | Increased CSF lactate (HP:0002490) | 3.83212082 |
| 13 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.82375763 |
| 14 | Aplastic anemia (HP:0001915) | 3.79264766 |
| 15 | Chromsome breakage (HP:0040012) | 3.76496938 |
| 16 | Oral leukoplakia (HP:0002745) | 3.69370103 |
| 17 | Hepatic necrosis (HP:0002605) | 3.68837385 |
| 18 | Progressive muscle weakness (HP:0003323) | 3.65475327 |
| 19 | Ragged-red muscle fibers (HP:0003200) | 3.57799014 |
| 20 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.54722259 |
| 21 | Increased intramyocellular lipid droplets (HP:0012240) | 3.48862154 |
| 22 | Cerebral hypomyelination (HP:0006808) | 3.44938649 |
| 23 | Rough bone trabeculation (HP:0100670) | 3.44905177 |
| 24 | Progressive macrocephaly (HP:0004481) | 3.44414044 |
| 25 | Cerebral edema (HP:0002181) | 3.42545214 |
| 26 | Lactic acidosis (HP:0003128) | 3.25285681 |
| 27 | Carpal bone hypoplasia (HP:0001498) | 3.11459035 |
| 28 | Exercise intolerance (HP:0003546) | 3.09957597 |
| 29 | Colon cancer (HP:0003003) | 3.05773573 |
| 30 | Increased muscle lipid content (HP:0009058) | 3.05106226 |
| 31 | Testicular atrophy (HP:0000029) | 3.04181588 |
| 32 | Abnormality of the anterior horn cell (HP:0006802) | 3.03999443 |
| 33 | Degeneration of anterior horn cells (HP:0002398) | 3.03999443 |
| 34 | Patellar aplasia (HP:0006443) | 2.99324027 |
| 35 | Abnormality of the preputium (HP:0100587) | 2.94287519 |
| 36 | Abnormal gallbladder physiology (HP:0012438) | 2.89164827 |
| 37 | Cholecystitis (HP:0001082) | 2.89164827 |
| 38 | Premature graying of hair (HP:0002216) | 2.85125778 |
| 39 | Macrocytic anemia (HP:0001972) | 2.83214365 |
| 40 | Abnormality of chromosome stability (HP:0003220) | 2.82301852 |
| 41 | Pallor (HP:0000980) | 2.81991527 |
| 42 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.80732015 |
| 43 | Meckel diverticulum (HP:0002245) | 2.75850959 |
| 44 | Abnormal trabecular bone morphology (HP:0100671) | 2.73463017 |
| 45 | Bone marrow hypocellularity (HP:0005528) | 2.71775773 |
| 46 | Lipid accumulation in hepatocytes (HP:0006561) | 2.66601184 |
| 47 | Myelodysplasia (HP:0002863) | 2.66112311 |
| 48 | IgM deficiency (HP:0002850) | 2.65852067 |
| 49 | Absent thumb (HP:0009777) | 2.65615242 |
| 50 | Thrombocytosis (HP:0001894) | 2.64904003 |
| 51 | Abnormality of the ileum (HP:0001549) | 2.62826426 |
| 52 | Selective tooth agenesis (HP:0001592) | 2.60259064 |
| 53 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.58549857 |
| 54 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.58549857 |
| 55 | Abnormal protein glycosylation (HP:0012346) | 2.58549857 |
| 56 | Abnormal glycosylation (HP:0012345) | 2.58549857 |
| 57 | Type I transferrin isoform profile (HP:0003642) | 2.56731123 |
| 58 | Premature ovarian failure (HP:0008209) | 2.49026205 |
| 59 | Microretrognathia (HP:0000308) | 2.46448352 |
| 60 | Respiratory failure (HP:0002878) | 2.46415900 |
| 61 | Multiple enchondromatosis (HP:0005701) | 2.46193599 |
| 62 | Secondary amenorrhea (HP:0000869) | 2.45881463 |
| 63 | Agnosia (HP:0010524) | 2.41433713 |
| 64 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.40846054 |
| 65 | Pancytopenia (HP:0001876) | 2.40214179 |
| 66 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.38776184 |
| 67 | Trismus (HP:0000211) | 2.37682393 |
| 68 | Cellular immunodeficiency (HP:0005374) | 2.36920094 |
| 69 | Lymphoma (HP:0002665) | 2.36403300 |
| 70 | Medulloblastoma (HP:0002885) | 2.34685390 |
| 71 | Respiratory difficulties (HP:0002880) | 2.33640282 |
| 72 | 11 pairs of ribs (HP:0000878) | 2.30403901 |
| 73 | Leukodystrophy (HP:0002415) | 2.28811293 |
| 74 | Absent radius (HP:0003974) | 2.28372754 |
| 75 | Duplicated collecting system (HP:0000081) | 2.28338773 |
| 76 | Progressive external ophthalmoplegia (HP:0000590) | 2.28193768 |
| 77 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.27367734 |
| 78 | Opisthotonus (HP:0002179) | 2.27171294 |
| 79 | Impulsivity (HP:0100710) | 2.25816755 |
| 80 | Emotional lability (HP:0000712) | 2.24261623 |
| 81 | Petechiae (HP:0000967) | 2.22044230 |
| 82 | Small intestinal stenosis (HP:0012848) | 2.20579538 |
| 83 | Duodenal stenosis (HP:0100867) | 2.20579538 |
| 84 | Cleft eyelid (HP:0000625) | 2.20078335 |
| 85 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.18838613 |
| 86 | Renal Fanconi syndrome (HP:0001994) | 2.16443650 |
| 87 | Muscle fiber atrophy (HP:0100295) | 2.15702514 |
| 88 | IgG deficiency (HP:0004315) | 2.15263353 |
| 89 | Combined immunodeficiency (HP:0005387) | 2.15055475 |
| 90 | Horseshoe kidney (HP:0000085) | 2.14775240 |
| 91 | Spastic paraparesis (HP:0002313) | 2.14533525 |
| 92 | Neoplasm of the pancreas (HP:0002894) | 2.13577735 |
| 93 | Irregular epiphyses (HP:0010582) | 2.09130971 |
| 94 | Type 2 muscle fiber atrophy (HP:0003554) | 2.08072051 |
| 95 | Aplasia involving forearm bones (HP:0009822) | 2.07364060 |
| 96 | Absent forearm bone (HP:0003953) | 2.07364060 |
| 97 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.07179834 |
| 98 | Dicarboxylic aciduria (HP:0003215) | 2.07179834 |
| 99 | Increased serum lactate (HP:0002151) | 2.06042214 |
| 100 | Lethargy (HP:0001254) | 2.05596237 |
| 101 | Progressive microcephaly (HP:0000253) | 2.04994105 |
| 102 | Reduced antithrombin III activity (HP:0001976) | 2.04212336 |
| 103 | Hypokinesia (HP:0002375) | 2.03327931 |
| 104 | Sloping forehead (HP:0000340) | 2.03084910 |
| 105 | Ectopic kidney (HP:0000086) | 2.02553797 |
| 106 | Triphalangeal thumb (HP:0001199) | 2.02049267 |
| 107 | Abnormality of T cells (HP:0002843) | 2.01170384 |
| 108 | Severe combined immunodeficiency (HP:0004430) | 2.00222905 |
| 109 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 1.99936906 |
| 110 | Tracheoesophageal fistula (HP:0002575) | 1.99183572 |
| 111 | Abnormality of T cell physiology (HP:0011840) | 1.99086962 |
| 112 | Abnormal lung lobation (HP:0002101) | 1.96704260 |
| 113 | CNS hypomyelination (HP:0003429) | 1.96337331 |
| 114 | Gout (HP:0001997) | 1.95554282 |
| 115 | Pulmonary fibrosis (HP:0002206) | 1.95053520 |
| 116 | Rhabdomyosarcoma (HP:0002859) | 1.94535042 |
| 117 | Microvesicular hepatic steatosis (HP:0001414) | 1.91251902 |
| 118 | Methylmalonic aciduria (HP:0012120) | 1.90601606 |
| 119 | Amaurosis fugax (HP:0100576) | 1.89171708 |
| 120 | Death in infancy (HP:0001522) | 1.88436030 |
| 121 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.88106028 |
| 122 | Abnormality of the renal collecting system (HP:0004742) | 1.88072954 |
| 123 | Abnormality of DNA repair (HP:0003254) | 1.87614591 |
| 124 | Abnormality of methionine metabolism (HP:0010901) | 1.86073411 |
| 125 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.85870877 |
| 126 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.85870877 |
| 127 | Abnormality of alanine metabolism (HP:0010916) | 1.85772111 |
| 128 | Hyperalaninemia (HP:0003348) | 1.85772111 |
| 129 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.85772111 |
| 130 | Exertional dyspnea (HP:0002875) | 1.85404250 |
| 131 | Sparse eyelashes (HP:0000653) | 1.85373268 |
| 132 | 3-Methylglutaconic aciduria (HP:0003535) | 1.85034208 |
| 133 | CNS demyelination (HP:0007305) | 1.84317161 |
| 134 | Poor head control (HP:0002421) | 1.83207079 |
| 135 | T lymphocytopenia (HP:0005403) | 1.83170749 |
| 136 | Rhabdomyolysis (HP:0003201) | 1.83125599 |
| 137 | Unilateral renal agenesis (HP:0000122) | 1.82853985 |
| 138 | Glossoptosis (HP:0000162) | 1.81991857 |
| 139 | Granulocytopenia (HP:0001913) | 1.79579017 |
| 140 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.79577247 |
| 141 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.79361578 |
| 142 | Abnormality of the duodenum (HP:0002246) | 1.78571724 |
| 143 | Ureteral duplication (HP:0000073) | 1.78564462 |
| 144 | Abnormality of placental membranes (HP:0011409) | 1.78296956 |
| 145 | Amniotic constriction ring (HP:0009775) | 1.78296956 |
| 146 | Megaloblastic anemia (HP:0001889) | 1.77193155 |
| 147 | Fasciculations (HP:0002380) | 1.75472840 |
| 148 | Squamous cell carcinoma (HP:0002860) | 1.74278521 |
| 149 | Increased hepatocellular lipid droplets (HP:0006565) | 1.74231109 |
| 150 | Short thumb (HP:0009778) | 1.73995568 |
| 151 | Leukopenia (HP:0001882) | 1.73308130 |
| 152 | Hypoplasia of the radius (HP:0002984) | 1.73223158 |
| 153 | Abnormality of T cell number (HP:0011839) | 1.73017221 |
| 154 | Hypergonadotropic hypogonadism (HP:0000815) | 1.72833778 |
| 155 | Abnormality of reticulocytes (HP:0004312) | 1.71360341 |
| 156 | Upper limb muscle weakness (HP:0003484) | 1.70827842 |
| 157 | Seborrheic dermatitis (HP:0001051) | 1.69075244 |
| 158 | Athetosis (HP:0002305) | 1.68391427 |
| 159 | Acute hepatic failure (HP:0006554) | 1.68271806 |
| 160 | Cholelithiasis (HP:0001081) | 1.66170465 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 4.59146177 |
| 2 | VRK2 | 4.09933582 |
| 3 | EIF2AK1 | 3.91658966 |
| 4 | WEE1 | 3.64284394 |
| 5 | CDC7 | 2.98426123 |
| 6 | SRPK1 | 2.76699335 |
| 7 | STK16 | 2.68865868 |
| 8 | NME2 | 2.68789124 |
| 9 | TSSK6 | 2.60894108 |
| 10 | EIF2AK3 | 2.46783112 |
| 11 | NEK2 | 2.27190708 |
| 12 | BRSK2 | 2.09991187 |
| 13 | SMG1 | 2.09956975 |
| 14 | PLK4 | 2.08555137 |
| 15 | VRK1 | 1.99256236 |
| 16 | TTK | 1.92326357 |
| 17 | TLK1 | 1.85798926 |
| 18 | MKNK1 | 1.79599430 |
| 19 | MAP4K1 | 1.73976952 |
| 20 | PLK1 | 1.73880756 |
| 21 | TESK2 | 1.57246422 |
| 22 | ZAK | 1.52968824 |
| 23 | ACVR1B | 1.51627753 |
| 24 | PIM2 | 1.50294779 |
| 25 | CCNB1 | 1.49954830 |
| 26 | ATR | 1.49859412 |
| 27 | CDK7 | 1.49743189 |
| 28 | AURKB | 1.48405933 |
| 29 | PLK3 | 1.43690429 |
| 30 | STK10 | 1.42905118 |
| 31 | MKNK2 | 1.42430078 |
| 32 | KDR | 1.40415294 |
| 33 | RPS6KA4 | 1.39687269 |
| 34 | DYRK3 | 1.35837114 |
| 35 | ARAF | 1.33794683 |
| 36 | TXK | 1.28321111 |
| 37 | NEK1 | 1.27813900 |
| 38 | IRAK3 | 1.27718151 |
| 39 | ERN1 | 1.21543105 |
| 40 | PRPF4B | 1.21275653 |
| 41 | PASK | 1.19835479 |
| 42 | DAPK1 | 1.18909845 |
| 43 | CDK4 | 1.14083770 |
| 44 | PIM1 | 1.13680808 |
| 45 | EPHA2 | 1.12349041 |
| 46 | TRIB3 | 1.11908724 |
| 47 | BRSK1 | 1.10736805 |
| 48 | LIMK1 | 1.10273594 |
| 49 | CHEK2 | 1.09097717 |
| 50 | RPS6KB2 | 1.08383040 |
| 51 | EIF2AK2 | 1.08165826 |
| 52 | PDK2 | 1.06694699 |
| 53 | MAP3K8 | 1.05465033 |
| 54 | AURKA | 1.05407128 |
| 55 | ZAP70 | 1.00826035 |
| 56 | CHEK1 | 0.97335850 |
| 57 | TEC | 0.96588247 |
| 58 | STK4 | 0.94996974 |
| 59 | MAP3K11 | 0.90409800 |
| 60 | IRAK4 | 0.89139385 |
| 61 | MST1R | 0.89005632 |
| 62 | MAPKAPK3 | 0.87795292 |
| 63 | TGFBR1 | 0.86175404 |
| 64 | BTK | 0.85763919 |
| 65 | MAP4K2 | 0.84321396 |
| 66 | PAK4 | 0.84246634 |
| 67 | CSNK1G3 | 0.81941969 |
| 68 | NEK9 | 0.79232322 |
| 69 | IKBKB | 0.74844169 |
| 70 | ATM | 0.72847966 |
| 71 | MAPK11 | 0.71547140 |
| 72 | CSNK2A1 | 0.70899740 |
| 73 | BCKDK | 0.70822995 |
| 74 | CSNK2A2 | 0.68332240 |
| 75 | NUAK1 | 0.68018928 |
| 76 | JAK3 | 0.67980159 |
| 77 | SCYL2 | 0.67867736 |
| 78 | BLK | 0.67806578 |
| 79 | ILK | 0.67416969 |
| 80 | MAP2K3 | 0.67086011 |
| 81 | CLK1 | 0.67078945 |
| 82 | NLK | 0.66349605 |
| 83 | TRIM28 | 0.66250230 |
| 84 | FLT3 | 0.66032981 |
| 85 | PBK | 0.65801549 |
| 86 | CDK2 | 0.64593760 |
| 87 | CDK12 | 0.64453159 |
| 88 | CDK8 | 0.63818946 |
| 89 | AKT2 | 0.62971746 |
| 90 | ABL2 | 0.61663263 |
| 91 | CSNK1A1L | 0.60399097 |
| 92 | CDK19 | 0.60169937 |
| 93 | PAK1 | 0.60156322 |
| 94 | MAPKAPK5 | 0.59017274 |
| 95 | PRKD3 | 0.58438524 |
| 96 | RPS6KA5 | 0.57691177 |
| 97 | MST4 | 0.55754672 |
| 98 | STK3 | 0.55693812 |
| 99 | TYK2 | 0.48928446 |
| 100 | NME1 | 0.48923381 |
| 101 | CHUK | 0.48366382 |
| 102 | TAOK2 | 0.46862634 |
| 103 | TESK1 | 0.46333143 |
| 104 | KIT | 0.45686189 |
| 105 | CDK9 | 0.45474511 |
| 106 | MAP3K10 | 0.45374218 |
| 107 | CDK1 | 0.45344023 |
| 108 | LYN | 0.45032350 |
| 109 | STK38L | 0.44856398 |
| 110 | MARK3 | 0.44708019 |
| 111 | BRD4 | 0.44666889 |
| 112 | RAF1 | 0.43784576 |
| 113 | LRRK2 | 0.43782802 |
| 114 | DAPK3 | 0.43720291 |
| 115 | ALK | 0.43658108 |
| 116 | MAP3K14 | 0.43429544 |
| 117 | PRKCI | 0.41320010 |
| 118 | EEF2K | 0.41201655 |
| 119 | TAF1 | 0.40641207 |
| 120 | ICK | 0.37998395 |
| 121 | MAP3K3 | 0.37168197 |
| 122 | CSF1R | 0.36954992 |
| 123 | DYRK2 | 0.35928959 |
| 124 | MELK | 0.35743482 |
| 125 | STK24 | 0.35419903 |
| 126 | BRAF | 0.35320213 |
| 127 | LCK | 0.34758445 |
| 128 | TBK1 | 0.34393702 |
| 129 | CSNK1G1 | 0.33678327 |
| 130 | CAMK2G | 0.30130310 |
| 131 | MAP3K12 | 0.28955587 |
| 132 | CSNK1G2 | 0.27404842 |
| 133 | CDK11A | 0.27106820 |
| 134 | SIK3 | 0.26696799 |
| 135 | INSRR | 0.26256073 |
| 136 | CDK14 | 0.26110086 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 4.45202404 |
| 2 | Mismatch repair_Homo sapiens_hsa03430 | 3.72807732 |
| 3 | * Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.67116846 |
| 4 | Proteasome_Homo sapiens_hsa03050 | 3.55506531 |
| 5 | Ribosome_Homo sapiens_hsa03010 | 3.53727255 |
| 6 | RNA polymerase_Homo sapiens_hsa03020 | 3.51985128 |
| 7 | Spliceosome_Homo sapiens_hsa03040 | 3.01960255 |
| 8 | RNA transport_Homo sapiens_hsa03013 | 2.85170482 |
| 9 | Base excision repair_Homo sapiens_hsa03410 | 2.85004058 |
| 10 | Homologous recombination_Homo sapiens_hsa03440 | 2.82341078 |
| 11 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.57488328 |
| 12 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.54420429 |
| 13 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.51953429 |
| 14 | Cell cycle_Homo sapiens_hsa04110 | 2.27699105 |
| 15 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.20718477 |
| 16 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.07581027 |
| 17 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.96528551 |
| 18 | Basal transcription factors_Homo sapiens_hsa03022 | 1.94666297 |
| 19 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.93045631 |
| 20 | RNA degradation_Homo sapiens_hsa03018 | 1.85151309 |
| 21 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.82038788 |
| 22 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.52372923 |
| 23 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.48206552 |
| 24 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.42239684 |
| 25 | Purine metabolism_Homo sapiens_hsa00230 | 1.36347947 |
| 26 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.27938925 |
| 27 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.27318663 |
| 28 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.26940767 |
| 29 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.23850580 |
| 30 | Protein export_Homo sapiens_hsa03060 | 1.23069241 |
| 31 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.21944510 |
| 32 | Alzheimers disease_Homo sapiens_hsa05010 | 1.15427615 |
| 33 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.10810292 |
| 34 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.09427374 |
| 35 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.07294029 |
| 36 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.01921011 |
| 37 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.99722597 |
| 38 | Sulfur relay system_Homo sapiens_hsa04122 | 0.97396224 |
| 39 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.97194566 |
| 40 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.97011217 |
| 41 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.94590162 |
| 42 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.92432922 |
| 43 | Legionellosis_Homo sapiens_hsa05134 | 0.92010891 |
| 44 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.86851453 |
| 45 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.81974069 |
| 46 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.79552075 |
| 47 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.76668451 |
| 48 | Measles_Homo sapiens_hsa05162 | 0.76474764 |
| 49 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.75756949 |
| 50 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.74882238 |
| 51 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.73631959 |
| 52 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.71743501 |
| 53 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.69903724 |
| 54 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.66233819 |
| 55 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.64415059 |
| 56 | HTLV-I infection_Homo sapiens_hsa05166 | 0.62317793 |
| 57 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.61913910 |
| 58 | Allograft rejection_Homo sapiens_hsa05330 | 0.61689319 |
| 59 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.60379447 |
| 60 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.59900410 |
| 61 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.59810413 |
| 62 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.59285639 |
| 63 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.58744334 |
| 64 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.58728583 |
| 65 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.56589695 |
| 66 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.54603289 |
| 67 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.52407907 |
| 68 | Apoptosis_Homo sapiens_hsa04210 | 0.52346343 |
| 69 | Thyroid cancer_Homo sapiens_hsa05216 | 0.51462995 |
| 70 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.50884782 |
| 71 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.47995327 |
| 72 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.47993215 |
| 73 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.46513660 |
| 74 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.46418694 |
| 75 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.44947119 |
| 76 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.44391209 |
| 77 | Leishmaniasis_Homo sapiens_hsa05140 | 0.43403956 |
| 78 | Huntingtons disease_Homo sapiens_hsa05016 | 0.42665293 |
| 79 | Shigellosis_Homo sapiens_hsa05131 | 0.41862430 |
| 80 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.40952333 |
| 81 | Carbon metabolism_Homo sapiens_hsa01200 | 0.40403474 |
| 82 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.40114085 |
| 83 | Asthma_Homo sapiens_hsa05310 | 0.39833541 |
| 84 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.39564835 |
| 85 | Influenza A_Homo sapiens_hsa05164 | 0.39544031 |
| 86 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.38674719 |
| 87 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.38244233 |
| 88 | Hepatitis B_Homo sapiens_hsa05161 | 0.37614182 |
| 89 | Other glycan degradation_Homo sapiens_hsa00511 | 0.37562786 |
| 90 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.37490150 |
| 91 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.35205177 |
| 92 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.34951474 |
| 93 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.34450416 |
| 94 | Peroxisome_Homo sapiens_hsa04146 | 0.32325251 |
| 95 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.31170372 |
| 96 | Metabolic pathways_Homo sapiens_hsa01100 | 0.30865631 |
| 97 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.30787156 |
| 98 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.30689325 |
| 99 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.30604156 |
| 100 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.29232450 |
| 101 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.27869873 |
| 102 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.26289601 |
| 103 | Parkinsons disease_Homo sapiens_hsa05012 | 0.26236443 |
| 104 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.24976684 |
| 105 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.24935722 |
| 106 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.24874935 |
| 107 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.21812431 |
| 108 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.21635982 |
| 109 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.21197872 |
| 110 | Galactose metabolism_Homo sapiens_hsa00052 | 0.20485266 |
| 111 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.19797747 |
| 112 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.19166529 |
| 113 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.19009751 |
| 114 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.18767076 |
| 115 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.18714110 |
| 116 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.18081926 |
| 117 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.16122111 |
| 118 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.14220256 |
| 119 | Viral myocarditis_Homo sapiens_hsa05416 | 0.14208095 |
| 120 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.13921594 |
| 121 | Bladder cancer_Homo sapiens_hsa05219 | 0.13881614 |
| 122 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.13827554 |
| 123 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.12905489 |
| 124 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.12218169 |
| 125 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.12138483 |
| 126 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.08124903 |
| 127 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.04671507 |
| 128 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.03208047 |
| 129 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.02932721 |

